Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL)

CAPS Rating: 2 out of 5

A specialty biopharmaceutical company with a focus on developing and marketing products to urologists, endocrinologists, orthopedists and select primary care physicians.

Recs

2
Player Avatar mblin13 (38.06) Submitted: 3/1/2007 12:57:53 PM : Outperform Start Price: $12.32 AUXL Score: +56.78

downside provided by testim;
other drugs in phase 3 trials;
stock could triple

Featured Broker Partners


Advertisement